Latest News for BAL
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of
[url="]Agenus Inc.[/url] (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that two posters highlighting research on botensilimab (BOT), a
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of mature Phase 1b results from t
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the inves
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BAL.
Senate Trading
No Senate trades found for BAL.
U.S. House Trading
No House trades found for BAL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.